Europe Neurosurgery Market Analysis

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE NEUROSURGERY MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 SOURCE LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

4.3 INDUSTRIAL INSIGHTS:

4.4 CONCLUSION

5 REGULATIONS OF THE EUROPE NEUROSURGERY MARKET

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 TECHNOLOGICAL ADVANCEMENT IN NEUROSURGERY

6.1.2 RISING PREVALENCE OF NEUROLOGICAL CONDITIONS

6.1.3 DEVELOPMENTS IN SURGICAL EQUIPMENT

6.2 RESTRAINTS

6.2.1 THE HIGH COST ASSOCIATED WITH NEUROSURGERIES AND EQUIPMENT

6.2.2 UNFAVOURABLE REIMBURSEMENT POLICIES

6.3 OPPORTUNITIES

6.3.1 RISING AWARENESS ABOUT NEUROLOGICAL DISORDERS

6.3.2 INCREASING NUMBER OF KEY PLAYERS IN MARKET

6.3.3 ADVANCE PRODUCT DEVELOPMENT AND LAUNCHES IN RECENT YEARS

6.4 CHALLENGES

6.4.1 ALTERNATIVE TREATMENTS FOR NEUROLOGICAL DISEASE

6.4.2 STRINGENT REGULATIONS FOR APPROVAL OF MEDICAL DEVICES

7 EUROPE NEUROSURGERY MARKET, BY PRODUCT TYPE

7.1 OVERVIEW

7.2 NEUROSURGERY DEVICES

7.2.1 NEUROMODULATION DEVICES

7.2.1.1 INTERNAL NEUROMODULATION DEVICES

7.2.1.1.1 SPINAL CORD STIMULATION DEVICES

7.2.1.1.1.1 RECHARGEABLE

7.2.1.1.1.2 NON- RECHARGEABLE

7.2.1.1.2 DEEP BRAIN STIMULATION DEVICES

7.2.1.1.2.1 SINGLE-CHANNEL DEEP BRAIN STIMULATION

7.2.1.1.2.2 DUAL-CHANNEL DEEP BRAIN STIMULATION

7.2.1.1.3 SACRAL NERVE STIMULATION DEVICES

7.2.1.1.3.1 IMPLANTABLE

7.2.1.1.3.2 EXTERNAL

7.2.1.1.4 VAGUS NERVE STIMULATION DEVICES

7.2.1.1.4.1 INVASIVE

7.2.1.1.4.2 EXTERNAL

7.2.1.1.5 GASTRIC ELECTRICAL STIMULATION DEVICES

7.2.1.1.5.1 LOW FREQUENCY GASTRIC ELECTRICAL STIMULATORS

7.2.1.1.5.2 HIGH FREQUENCY GASTRIC ELECTRICAL STIMULATORS

7.2.1.1.6 EXTERNAL NEUROMODULATION DEVICES

7.2.1.1.6.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)

7.2.1.1.6.2 TRANSCRANIAL MAGNETIC STIMULATION (TMS)

7.2.1.1.6.3 OTHERS

7.2.2 NEURO-INTERVENTIONAL DEVICES

7.2.2.1 EMBOLIZATION COILS

7.2.2.1.1 DETACHABLE

7.2.2.1.2 PUSHABLE

7.2.2.2 CAROTID STENTS

7.2.2.3 INTRACRANIAL STENTS

7.2.2.4 NEUROVASCULAR THROMBECTOMY

7.2.2.4.1 COIL RETRIEVERS

7.2.2.4.2 ASPIRATION DEVICES

7.2.2.4.3 STENT RETRIEVERS

7.2.2.5 INTRASSACULAR DEVICES

7.2.2.6 BALLOONS

7.2.2.7 OTHERS

7.2.3 NEUROSURGERY SURGICAL POWER TOOLS

7.2.3.1 DRILL

7.2.3.1.1 PNEUMATIC NEUROSURGICAL DRILLS

7.2.3.1.2 ELECTRICAL NEUROSURGICAL DRILLS

7.2.3.2 SAW

7.2.3.3 OTHERS

7.2.4 NEUROSURGICAL NAVIGATION SYSTEMS

7.2.5 CEREBROSPINAL FLUID (CSF) MANAGEMENT DEVICES

7.2.5.1 CSF SHUNTS

7.2.5.2 EXTERNAL DRAINAGE SYSTEM

7.2.6 NEUROSURGICAL MICROSCOPE

7.2.7 CRANIAL STABILIZATION

7.2.8 NEUROENDOSCOPY DEVICES

7.2.9 INTRA OPERATIVE IMAGING

7.2.10 BRAIN MONITORING

7.2.11 NEUROSURGICAL EVACUATION DEVICES

7.2.12 STEREOTACTIC SYSTEMS

7.2.13 ULTRASONIC ASPIRATOR

7.2.14 BIPOLAR EQUIPMENT

7.3 NEUROSURGERY SOFTWARE

7.3.1 IMAGING NEUROSURGERY SOFTWARE

7.3.2 PRE-OPERATION PLANNING NEUROSURGERY SOFTWARE

7.3.3 OTHERS

7.4 CONSUMABLES

8 EUROPE NEUROSURGERY MARKET, BY AGE GROUP

8.1 OVERVIEW

8.2 PEDIATRIC

8.3 ADULT

8.4 GERIATRIC

9 EUROPE NEUROSURGERY MARKET, BY APPLICATION

9.1 OVERVIEW

9.2 BRAIN TUMORS

9.3 TRAUMA SURGERY

9.4 SPINE SURGERY

9.5 PARKINSON’S DISEASE AND TREMORS

9.6 PERIPHERAL NERVE SURGERY

9.7 EPILEPSY

9.8 FUNCTIONAL NEUROSURGERY

9.9 CAROTID ARTERY BLOCKAGE/STENOSIS

9.1 INTRAOPERATIVE ANGIOGRAPHY

9.11 CEREBROVASCULAR SURGERY

9.12 ANEURYSMS

9.13 PITUITARY TUMORS

9.14 RADIOSURGERY

9.15 STEREOTACTIC NEUROSURGERY

9.16 CORTICAL MAPPING

9.17 ARTERIOVENOUS MALFUNCTION (AVM)

9.18 SKULL BASE SURGERY

9.19 TRIGEMINAL NEURALGIA

9.2 OTHERS

10 EUROPE NEUROSURGERY MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.2.1 ACUTE CARE HOSPITALS

10.2.2 LONG-TERM CARE HOSPITALS

10.2.3 NURSING FACILITIES

10.2.4 REHABILITATION CENTERS

10.3 RESEARCH CENTERS

10.4 NEUROSURGERY CENTERS

10.5 AMBULATORY SURGICAL CENTERS (ASCS)

10.6 OTHERS

11 EUROPE NEUROSURGERY MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 DIRECT TENDER

11.3 THIRD PARTY DISTRIBUTORS

11.4 OTHERS

12 EUROPE NEUROSURGERY MARKET, BY REGION

12.1 EUROPE

12.1.1 GERMANY

12.1.2 FRANCE

12.1.3 U.K.

12.1.4 ITALY

12.1.5 RUSSIA

12.1.6 SPAIN

12.1.7 TURKEY

12.1.8 NETHERLANDS

12.1.9 SWITZERLAND

12.1.10 BELGIUM

12.1.11 REST OF EUROPE

13 EUROPE NEUROSURGERY MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: EUROPE

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 MEDTRONIC

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.2 STRYKER

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENT

15.3 ABBOTT

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENT

15.4 BOSTON SCIENTIFIC CORPORATION OR ITS AFFILIATES.

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENTS

15.5 INTEGRA LIFESCIENCES (2021)

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENT

15.6 ADEOR MEDICAL AG

15.6.1 COMPANY SNAPSHOT

15.6.2 PRODUCT PORTFOLIO

15.6.3 RECENT DEVELOPMENTS

15.7 ADVANTIS MEDICAL IMAGING

15.7.1 COMPANY SNAPSHOT

15.7.2 PRODUCT PORTFOLIO

15.7.3 RECENT DEVELOPMENT

15.8 ALEVA NEUROTHERAPEUTICS

15.8.1 COMPANY SNAPSHOT

15.8.2 PRODUCT PORTFOLIO

15.8.3 RECENT DEVELOPMENTS

15.9 ANT NEURO

15.9.1 COMPANY SNAPSHOT

15.9.2 PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENT

15.1 B. BRAUN SE

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENTS

15.11 BIOINDUCTION

15.11.1 COMPANY SNAPSHOT

15.11.2 PRODUCT PORTFOLIO

15.11.3 RECENT DEVELOPMENT

15.12 BRAINLAB AG

15.12.1 COMPANY SNAPSHOT

15.12.2 PRODUCT PORTFOLIO

15.12.3 RECENT DEVELOPMENTS

15.13 ELEKTA

15.13.1 COMPANY SNAPSHOT

15.13.2 REVENUE ANALYSIS

15.13.3 PRODUCT PORTFOLIO

15.13.4 RECENT DEVELOPMENTS

15.14 EMS HANDELS GESELLSCHAFT MBH

15.14.1 COMPANY SNAPSHOT

15.14.2 PRODUCT PORTFOLIO

15.14.3 RECENT DEVELOPMENT

15.15 INOMED MEDIZINTECHNIK GMBH

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 KARL STORZ SE & CO. KG

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENT

15.17 LEICA MICROSYSTEMS

15.17.1 COMPANY SNAPSHOT

15.17.2 PRODUCT PORTFOLIO

15.17.3 RECENT DEVELOPMENT

15.18 LIVANOVA PLC

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 PRODUCT PORTFOLIO

15.18.4 RECENT DEVELOPMENTS

15.19 NEVRO CORP.

15.19.1 COMPANY SNAPSHOT

15.19.2 REVENUE ANALYSIS

15.19.3 PRODUCT PORTFOLIO

15.19.4 RECENT DEVELOPMENTS

15.2 OPTOFINE INSTRUMENTS PVT. LTD.

15.20.1 COMPANY SNAPSHOT

15.20.2 PRODUCT PORTFOLIO

15.20.3 RECENT DEVELOPMENTS

15.21 PENUMBRA, INC.

15.21.1 COMPANY SNAPSHOT

15.21.2 REVENUE ANALYSIS

15.21.3 PRODUCT PORTFOLIO

15.21.4 RECENT DEVELOPMENTS

15.22 RENISHAW PLC.

15.22.1 COMPANY SNAPSHOT

15.22.2 REVENUE ANALYSIS

15.22.3 PRODUCT PORTFOLIO

15.22.4 RECENT DEVELOPMENT

15.23 SYNAPSE BIOMEDICAL INC.

15.23.1 COMPANY SNAPSHOT

15.23.2 PRODUCT PORTFOLIO

15.23.3 RECENT DEVELOPMENT

15.24 TERUMO MEDICAL CORPORATION

15.24.1 COMPANY SNAPSHOT

15.24.2 REVENUE ANALYSIS

15.24.3 PRODUCT PORTFOLIO

15.24.4 RECENT DEVELOPMENTS

15.25 MACHIDA ENDOSCOPE CO., LTD.

15.25.1 COMPANY SNAPSHOT

15.25.2 PRODUCT PORTFOLIO

15.25.3 RECENT DEVELOPMENTS

15.26 NALU MEDICAL, INC.

15.26.1 COMPANY SNAPSHOT

15.26.2 PRODUCT PORTFOLIO

15.26.3 RECENT DEVELOPMENT

15.27 WALLABY MEDICAL

15.27.1 COMPANY SNAPSHOT

15.27.2 PRODUCT PORTFOLIO

15.27.3 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS